Conatus Pharmaceuticals has announced the appointment of Daniel Ripley as head of Corporate Development. Ripley will lead the commercialisation strategy …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

